Gender-Specific Behaviour in Obesity Stages I-II: Imbalance of Aminothiol Status and Adipomyokine Profile in Subjects with Different Insulin Resistance Severity.
Journal
Oxidative medicine and cellular longevity
ISSN: 1942-0994
Titre abrégé: Oxid Med Cell Longev
Pays: United States
ID NLM: 101479826
Informations de publication
Date de publication:
2021
2021
Historique:
received:
29
06
2021
revised:
11
10
2021
accepted:
11
11
2021
entrez:
6
12
2021
pubmed:
7
12
2021
medline:
23
2
2022
Statut:
epublish
Résumé
The hyperproduction of oxidative stress and inflammatory biomarkers, which is paralleled by decreased levels of antioxidant and anti-inflammatory mediators, is part of cellular mechanisms that contribute to the disruption of metabolic homeostasis in obesity. Whether gender-specific alterations and gender-restricted associations in these biomarkers underlie the increased cardiometabolic risk in men compared to women is unclear. We enrolled 31 women and 29 men, aged ≥50 and ≤70 years and with body mass index ≥ 30 and <40 kg/m
Identifiants
pubmed: 34868459
doi: 10.1155/2021/9713582
pmc: PMC8635872
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9713582Informations de copyright
Copyright © 2021 Jonica Campolo et al.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Annu Rev Cell Dev Biol. 2004;20:61-86
pubmed: 15473835
Aging Cell. 2011 Dec;10(6):931-48
pubmed: 21771249
Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):418-24
pubmed: 12615666
Genes Dev. 2021 Mar 1;35(5-6):307-328
pubmed: 33649162
Obesity (Silver Spring). 2012 Mar;20(3):473-81
pubmed: 21546934
Diabetes. 2014 Jul;63(7):2216-8
pubmed: 24962921
Obesity (Silver Spring). 2009 Jul;17(7):1435-40
pubmed: 19214177
Nutr Metab (Lond). 2017 Mar 21;14:29
pubmed: 28344633
J Clin Invest. 2013 Dec;123(12):4992-3
pubmed: 24292661
Exp Clin Endocrinol Diabetes. 2019 Sep;127(8):550-556
pubmed: 30075479
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):1787-1800
pubmed: 32460579
J Clin Invest. 2004 Dec;114(12):1752-61
pubmed: 15599400
Curr Drug Targets. 2014;15(8):811-5
pubmed: 24958098
Diabetes Metab Syndr. 2016 Jan-Mar;10(1 Suppl 1):S86-9
pubmed: 26482051
Circ Res. 2016 May 27;118(11):1786-807
pubmed: 27230642
Med Sci Monit. 2016 Oct 13;22:3673-3679
pubmed: 27733746
Diabetes Care. 2010 Apr;33(4):920-2
pubmed: 20067971
Am J Physiol Endocrinol Metab. 2008 May;294(5):E918-27
pubmed: 18334608
Obes Res Clin Pract. 2013 Sep-Oct;7(5):e330-41
pubmed: 24455761
Mol Nutr Food Res. 2017 Nov;61(11):
pubmed: 28722287
Redox Biol. 2017 Aug;12:389-402
pubmed: 28319890
Nutrients. 2019 Nov 05;11(11):
pubmed: 31694146
Int J Mol Sci. 2011;12(5):3117-32
pubmed: 21686173
Free Radic Biol Med. 2021 Nov 1;175:108-120
pubmed: 34390781
Front Endocrinol (Lausanne). 2018 Jan 31;9:5
pubmed: 29445355
J Intern Med. 2000 Apr;247(4):457-62
pubmed: 10792559
Ann Ig. 2016 May-Jun;28(3):179-86
pubmed: 27297194
Peptides. 2018 Sep;107:25-31
pubmed: 30076861
Lancet. 2005 Oct 1;366(9492):1197-209
pubmed: 16198769
Mol Cell Endocrinol. 2015 Feb 15;402:113-9
pubmed: 25578600
Metab Syndr Relat Disord. 2010 Feb;8(1):53-8
pubmed: 19958158
Am J Clin Nutr. 1992 May;55(5):950-4
pubmed: 1570802
Med Sci Sports Exerc. 2010 Nov;42(11):2023-9
pubmed: 20386333
Med Clin (Barc). 2001 Nov 3;117(14):530-3
pubmed: 11707218
Cell Metab. 2013 Oct 1;18(4):470-7
pubmed: 23954640
Mediators Inflamm. 2009;2009:959281
pubmed: 19707530
Diabetes Res Clin Pract. 2018 Aug;142:195-202
pubmed: 29859272
Free Radic Res. 1999 Jul;31(1):23-34
pubmed: 10489117
Int J Cardiol. 2007 Apr 12;117(1):45-50
pubmed: 16884794
Annu Rev Nutr. 2004;24:481-509
pubmed: 15189129